Key result
In hypertensive patients, a decline in eGFR of ≥5% per year significantly increased the risk of first stroke (HR 2.13) compared to a stable eGFR.
Why the study?
The association between changes in estimated glomerular filtration rate over time and stroke risk remained inconclusive.
Does a significant change in eGFR over time (either decline or increase) increase the risk of first stroke in hypertensive patients?
Cohort (n=11,742)
Yes
Does a significant change in eGFR over time (either decline or increase) increase the risk of first stroke in hypertensive patients?
In hypertensive patients, both a rapid decline and a rapid increase in eGFR over time are independently associated with an increased risk of first stroke, suggesting that eGFR trajectory is a valuable prognostic marker.
eGFR trajectory may refine stroke risk stratification in hypertension; hypothesis-generating and requires prospective validation before guiding care.
BACKGROUND: The association between changes in estimated glomerular filtration rate (eGFR) over time and the risk of stroke remains inconclusive. We aimed to evaluate the relation of eGFR change during the China Stroke Primary Prevention Trial (CSPPT) with the risk of first stroke during the subsequent post-trial follow-up. METHODS: A total of 11,742 hypertensive participants with two eGFR measurements (median measure interval, 4.4; interquartile range, 4.2-4.6 years) and without a history of stroke from the CSPPT were included in this analysis. RESULTS: Over a median post-trial follow-up of 4.4 years, 729 first strokes were identified, of which 635 were ischemic, 88 were hemorrhagic, and 6 were uncertain types of strokes. Compared with those with 1 to <2% per year increase in eGFR (with the lowest stroke risk), those with an increase in eGFR of ≥4% per year had significantly increased risks of first stroke (adjusted hazard ratio [HR] 1.96; 95% confidence interval [CI], 1.10-3.50) and first ischemic stroke (adjusted HR 2.14; 95% CI, 1.17-3.90). Similarly, those with a decline in eGFR of ≥5% per year also had significantly increased first stroke (adjusted HR 2.13; 95% CI, 1.37-3.31) and first ischemic stroke (adjusted HR 1.89; 95% CI, 1.19-3.02) risk. However, there was no significant association between eGFR change and first hemorrhagic stroke. A similar result was found when the change in eGFR was quantified as an absolute annual change. CONCLUSION: In Chinese hypertensive patients, both the decline and increase of eGFR levels were independently associated with the risks of first stroke or first ischemic stroke.
No takes yet. Share an insight, caveat, or question.
He et al. (2022) conducted a cohort in Hypertension (n=11,742). Decline in eGFR of ≥5% per year vs. 1 to <2% per year increase in eGFR was evaluated on First stroke (HR 2.13, 95% CI 1.37-3.31, p=<0.001). In hypertensive patients, a decline in eGFR of ≥5% per year significantly increased the risk of first stroke (HR 2.13) compared to a stable eGFR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: